A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether docetaxel, cisplatin, and capecitabine
(DCX) are effective as the neoadjuvant chemotherapy before esophagectomy in patients with
loco-regional esophageal squamous cell carcinoma (ESCC).